WIXOM, Mich., Sept. 21, 2011 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron-deficiency anemia, announced today that Robert L. Chioini, Chairman and Chief Executive Officer, along with Dr. Ajay Gupta, Chief Scientific Officer, will present at the JMP Securities Healthcare Conference taking place on September 27, 2011 at the St. Regis New York.
